Tailoring Treatment in Diabetes: The Patient as the Blueprint-GLP-1 RAs vs SGLT2 Inhibitors in Cardiovascular Outcomes
Witnessing the paradigm shift to NCDs calls for ever-evolving changes in how we treat patients with DM type 2,…
Browsing Category
2 articles
Amidst the Medico-Legal Ambiguities in Differentiating Hanging from Strangulation
Even if one could draw very careful lines between various asphyxial deaths, it is imperative not to limit our…
